GeneSpect Reporter for Pharmacogenomics

GeneSpect Reporter for Pharmacogenomics

Comprehensive recommendations for personalized drug selection tailored

to specific genotypes.

Logo

Accelerate effective drug treatment with personalized recommendations based on genetic profile

GeneSpect PGx Reporter is a solution powered by the iFlow Engine that provides personalized dosing recommendations using industry-standard sources. Starting from fastq or vcf files, it produces a comprehensive and detailed patient report with drug choices and dosing recommendations. GeneSpect PGx Reporter leverages the power of Intelliseq’s proprietary algorithm, Intelliseq Polygenic™, to identify star allele diplotypes and translate them into individual rates of drug metabolism.

Step 1
Step icon

Genotyping of raw NGS data

Advanced NGS data processing and quality check to identify SNVs, INDELS and SV of pharmacogenes.
Step 2
Step icon

Intelliseq Polygenic Algorithm

Advanced proprietary algorithm predicts the most probable haplotype pairs and assigns star-alleles for the well-established pharmacogenes such as: • CYP2D6 • CYP2C19 • DPYD • NUDT15 • SLCO1B1
Step 3
Step icon

Metabolizing Rate

Star allele diplotypes are used to assign the most likely phenotype, then translate and assign a predicted metabolism rate (i.e. poor, normal, intermediate, rapid metabolizer) based on the individual’s genetic profile.
Step 4
Step icon

Personalized recommendations

Aggregating and processing the information from industry-standard source databases to provide patient-specific drug choice and individual dosing recommendations. Analyzed medication types include >200 drugs from areas such as pain management, psychiatry, and cardiovascular.
Logo

Accelerate effective drug treatment with personalized recommendations based on genetic profile

GeneSpect PGx Reporter is a solution powered by the iFlow Engine that provides personalized dosing recommendations using industry-standard sources. Starting from fastq or vcf files, it produces a comprehensive and detailed patient report with drug choices and dosing recommendations. GeneSpect PGx Reporter leverages the power of Intelliseq’s proprietary algorithm, Intelliseq Polygenic™, to identify star allele diplotypes and translate them into individual rates of drug metabolism.

Step 1
Step icon

Genotyping of raw NGS data

Advanced NGS data processing and quality check to identify SNVs, INDELS and SV of pharmacogenes.
Step 2
Step icon

Intelliseq Polygenic Algorithm

Advanced proprietary algorithm predicts the most probable haplotype pairs and assigns star-alleles for the well-established pharmacogenes such as: • CYP2D6 • CYP2C19 • DPYD • NUDT15 • SLCO1B1
Step 3
Step icon

Metabolizing Rate

Star allele diplotypes are used to assign the most likely phenotype, then translate and assign a predicted metabolism rate (i.e. poor, normal, intermediate, rapid metabolizer) based on the individual’s genetic profile.
Step 4
Step icon

Personalized recommendations

Aggregating and processing the information from industry-standard source databases to provide patient-specific drug choice and individual dosing recommendations. Analyzed medication types include >200 drugs from areas such as pain management, psychiatry, and cardiovascular.

Reliable recommendations

GeneSpect PGx Reporter aggregates guidance from knowledge resources including:

GeneSpect PGx Reporter aggregates guidance from knowledge resources including:

FDA

Pharmacogenomic Biomarkers in Drug Labeling (by FDA)

CPIC

Clinical Pharmacogenetics Implementation Consortium

DPWG

The Royal Dutch Association for the Advancement of Pharmacy–Pharmacogenetics Working Group

PharmGKB

The Pharmacogenomics Knowledgebase

Intelliseq’s Polygenic algorithm sits at the heart of our PGx pipelines. It uses phased and unphased information about SNVs and SVs in a form of VCF in combination with schematic descriptions of over 20 pharmacogenes, such as CYP2D6, DPYD, NUDT15, SLCO1B1, in a form of .yml. As an output, it provides detailed information about possible and most probable diplotypes, together with information about missing and nonmissing genotype information as a structured json. It is highly flexible in terms of adding the new schematic gene representations and updating the old ones.

Intelliseq’s Polygenic algorithm sits at the heart of our PGx pipelines. It uses phased and unphased information about SNVs and SVs in a form of VCF in combination with schematic descriptions of over 20 pharmacogenes, such as CYP2D6, DPYD, NUDT15, SLCO1B1, in a form of .yml. As an output, it provides detailed information about possible and most probable diplotypes, together with information about missing and nonmissing genotype information as a structured json. It is highly flexible in terms of adding the new schematic gene representations and updating the old ones.

An extensive set of pharmacogenes analyzed

An extensive set of pharmacogenes analyzed

GeneSpect PGx Reporter provides details of over 20 genes including:

GeneSpect PGx Reporter provides details of over 20 genes including:

Rapidly generated

Rapidly generated and easily accessible reports

Rapidly generated and easily accessible reports

Rapidly generated and easily accessible reports

Rapidly generated and easily accessible reports

Fast turnaround time: from fastq file to final report in < 4h

User-friendly cloud-based interface to upload samples and run analysis

Cost-effectiveness pay-per-analysis pricing

Product details

Benefits

Benefits

Effective Medications

Assign the most effective drug dose tailored to a patient’s genotype to maximize its therapeutic effect.

Assign the most effective drug dose tailored to a patient’s genotype to maximize its therapeutic effect.

Avoid Adverse Drug Reaction (ADR)

Minimize the risk of adverse drug reactions (ADRs) by choosing the medication likely to be efficiently metabolized by individuals according to their star-allele status.

Minimize the risk of adverse drug reactions (ADRs) by choosing the medication likely to be efficiently metabolized by individuals according to their star-allele status.

Get Credible Recommendations

Aggregating and processing the information from industry-standard source databases

Aggregating and processing the information from industry-standard source databases

Book a demo with us today

Book a demo with us today

Book a demo with us today

Book a demo with us today

We deliver an intuitive cloud-based platform for NGS data analysis and clinical interpretation. We deliver an intuitive cloud-based.

Check available flyers

Check available flyers

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer pharetra eros vitae pellentesque consequat.

Intelliseq C-corp



Murrieta Regional Technology Innovation Center
26442 Beckman Court
City of Murrieta
County of Riverside
State of California, USA

contact@intelliseq.com

Resources



Case studies

Publications

Company

About us

Press

Careers

Copyright

Intelliseq © 2025

Security Policies Overview

GDPR

Newsletter

Intelliseq C-corp



Murrieta Regional Technology Innovation Center
26442 Beckman Court
City of Murrieta
County of Riverside
State of California, USA

contact@intelliseq.com

Resources



Case studies

Publications

Company

About us

Press

Careers

Copyright

Intelliseq © 2025

Security Policies Overview

GDPR

Newsletter

Intelliseq C-corp



Murrieta Regional Technology Innovation Center
26442 Beckman Court
City of Murrieta
County of Riverside
State of California, USA

contact@intelliseq.com

Resources



Case studies

Publications

Company

About us

Press

Careers

Copyright

Intelliseq © 2025

Security Policies Overview

GDPR

Newsletter

Intelliseq C-corp



Murrieta Regional Technology Innovation Center
26442 Beckman Court
City of Murrieta
County of Riverside
State of California, USA

contact@intelliseq.com

Resources



Case studies

Publications

Company

About us

Press

Careers

Copyright

Intelliseq © 2025

Security Policies Overview

GDPR

Newsletter

Intelliseq C-corp



Murrieta Regional Technology Innovation Center
26442 Beckman Court
City of Murrieta
County of Riverside
State of California, USA

contact@intelliseq.com

Resources



Case studies

Publications

Company

About us

Press

Careers

Copyright

Intelliseq © 2025

Security Policies Overview

GDPR

Newsletter